• Home
  • Cyclin-dependent kinase 4/6 inhibition in the treatment of hormone receptor-positive breast cancer.

Cyclin-dependent kinase 4/6 inhibition in the treatment of hormone receptor-positive breast cancer.

Author List
Rugo HS
Publication
Clinical advances in hematology & oncology : H&O
Publication ID (Profile URL)
https://researcherprofiles.org/profile/80105087
Publication Year
2019
PubMed ID
31730581
Publication Title
Rugo HS. Cyclin-dependent kinase 4/6 inhibition in the treatment of hormone receptor-positive breast cancer. Clin Adv Hematol Oncol. 2019 10; 17(10):555-558.